Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers

A single daily low dose of aspirin significantly reduced hepatic fat fraction and liver transaminase levels in a randomized trial in patients with metabolic-associated steatotic liver disease.

Related Keywords

Massachusetts ,United States ,Boston ,Marye Mccarthy Rinella ,Mark Hartman ,Robertm Wilechansky ,Significant Weight Gain In Placebo Group ,Eli Lilly Co ,Drug Administration ,University Of Chicago Pritzker School Medicine ,Massachusetts General Hospital ,Liver Meeting ,American Association ,Liver Diseases ,Medscape Medical ,Eli Lilly ,Weight Gain ,Placebo Group ,Carthy Rinella ,Chicago Pritzker School ,Nonalcoholic Fatty Liver Disease ,Vafld ,Biliary Disease ,Allbladder Disease ,Aspirin ,Hepatocellular Carcinoma ,Liver Cancer ,Dcc ,Hepatocellular Cancer ,Ancer Liver ,Ancer Hepatocellular ,Metabolic Syndrome ,Liver ,Aminotransferase ,Dust ,Liver Enzymes ,Liver Studies ,Olt ,Liver Disease ,Liver Biopsy ,Cirrhosis ,Metabolism ,Etabolic ,Weight Management ,Gastroesophageal Reflux Disease Gerd ,Astroes ,